0.68 - 0.75
0.33 - 0.86
18.36M / 4.66M (Avg.)
34.50 | 0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-12.49%
Negative revenue growth while 0425.HK stands at 12.12%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-5.93%
Negative gross profit growth while 0425.HK is at 3.76%. Joel Greenblatt would examine cost competitiveness or demand decline.
-38.09%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-38.09%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-46.61%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-58.14%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-58.14%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
27.41%
Share count expansion well above 0425.HK's 0.34%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
27.49%
Diluted share count expanding well above 0425.HK's 0.38%. Michael Burry would fear significant dilution to existing owners' stakes.
-100.00%
Both companies cut dividends. Martin Whitman would look for a common factor, such as cyclical downturn or liquidity constraints.
-60.86%
Negative OCF growth while 0425.HK is at 50.06%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-86.70%
Negative FCF growth while 0425.HK is at 144.89%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
60253.69%
10Y revenue/share CAGR above 1.5x 0425.HK's 1068.07%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
-22.50%
Negative 5Y CAGR while 0425.HK stands at 140.50%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-3.23%
Negative 3Y CAGR while 0425.HK stands at 59.84%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
1252.02%
10Y OCF/share CAGR above 1.5x 0425.HK's 498.86%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
382.08%
5Y OCF/share CAGR above 1.5x 0425.HK's 92.38%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
1336.12%
3Y OCF/share CAGR above 1.5x 0425.HK's 58.71%. David Dodd would confirm if the firm is quickly gaining an operational edge over the competitor.
334.84%
Net income/share CAGR at 50-75% of 0425.HK's 528.94%. Martin Whitman might question if the firm’s product or cost base lags behind.
115.27%
5Y net income/share CAGR above 1.5x 0425.HK's 64.67%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
911.33%
3Y net income/share CAGR above 1.5x 0425.HK's 21.36%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
No Data
No Data available this quarter, please select a different quarter.
326.15%
5Y equity/share CAGR above 1.5x 0425.HK's 87.15%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
52.13%
3Y equity/share CAGR above 1.5x 0425.HK's 33.37%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Both lowered dividends mid-term. Martin Whitman might suspect broad sector constraints or strategic shifts from dividends.
-100.00%
Both firms reduced dividends recently. Martin Whitman suspects broader macro or industry issues forcing cost and payout cuts.
-14.25%
Firm’s AR is declining while 0425.HK shows 2.56%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
19.80%
Inventory growth well above 0425.HK's 12.28%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
-6.28%
Negative asset growth while 0425.HK invests at 6.27%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-19.68%
We have a declining book value while 0425.HK shows 6.77%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
-40.86%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
-10.61%
Our R&D shrinks while 0425.HK invests at 12.70%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
1.66%
SG&A declining or stable vs. 0425.HK's 7.19%. David Dodd sees better overhead efficiency if it doesn't hamper revenue.